Volvo Largest Bus Brand in Sweden and Nordic Region
January 27, 2003 05:38 ET
|
Volvo
GOTEBORG, Sweden, Jan. 27, 2003 (PRIMEZONE) -- Volvo (Nasdaq:VOLVY):
Again in 2002, Volvo Buses was the distinct market leader in Sweden and increased its market share from 52.4% to 57.1% in the...
Media Release
January 27, 2003 04:45 ET
|
Novartis Pharma AG
For release content, please refer to the attachment....
Media Release
January 27, 2003 04:45 ET
|
Novartis Pharma AG
For release content, please refer to the attachment....
Teleca Develops Simulator in Gothenburg for Swedish National Road Administration
January 27, 2003 04:14 ET
|
Teleca
MALMO, Sweden, Jan. 27, 2003 (PRIMEZONE) -- Benima, part of the Teleca (Stockholm:TELCb) group, has signed a contract with the Swedish National Road Administration (SNRA) to develop a training...
Nokia and Signa Services join forces to accelerate public wireless LAN roll outs
January 27, 2003 04:05 ET
|
Nokia Oyj
The cooperation between Nokia and Signa Services opens new roads in bringing Nokia's wireless LAN solutions to corporate users. It will also support mobility operators and wireless Internet...
Goran Lenkel Named President of SkandiaBanken
January 27, 2003 03:32 ET
|
Skandia
STOCKHOLM, Sweden, Jan. 27, 2003 (PRIMEZONE) -- Goran Lenkel has been named as the new President of SkandiaBanken. SkandiaBanken operates in two parts, an Internet Bank and an Advisory Bank, and...
Getinge AB: Financial Statement 2002
January 27, 2003 02:46 ET
|
Getinge
STOCKHOLM, Sweden, Jan. 27, 2003 (PRIMEZONE) -- Getinge AB (Other OTC:GNGBF):
FINANCIAL STATEMENT 2002
-- The profit before tax climbed by 25% in Q4 to SEK 405.0
million (324.6 m)
-- The...
Crucell and Aventis Pasteur Sign License Agreement for Manufacturing Viral Vaccines
January 27, 2003 02:40 ET
|
Crucell N.V.
LEIDEN, The Netherlands, Jan. 27, 2003 (PRIMEZONE) -- Crucell N.V. (Nasdaq:CRXL) and Aventis Pasteur S.A. (NYSE:AVE) today announced that they have signed a commercial license agreement for...
Crucell Reports 2002 Annual Results
January 27, 2003 02:29 ET
|
Crucell N.V.
LEIDEN, The Netherlands, Jan. 27, 2003 (PRIMEZONE) -- Crucell N.V. (Nasdaq:CRXL) today announced its 2002 financial results. Total revenues for the year ended December 31, 2002 are $9.6 million...
Novartis European Young Investigator Award in Chemistry 2002 geht an Bernhard Breit und Thomas Carell
January 27, 2003 02:00 ET
|
Novartis Pharma AG
Novartis unterstreicht nachhaltige Verpflichtung zu wissenschaftlicher Exzellenz und Innovation in der ChemieBasel, 27. Januar 2003 - Der Novartis European Young Investigator Award in Chemistry...
- July 17, 2024 11:22 ET Global e-Prescription Systems Business Research Report 2024: Market to Reach $5.2 Billion by 2030 from $1.7 Billion in 2023 - Rising Demand for Telehealth Services Expands Opportunities
- July 17, 2024 11:16 ET Metaverse in Healthcare Global Strategic Report 2024: Market to Grow by Almost $150 Billion by 2030 - 3D Virtual Clinics Strengthen the Business Case, Digital Twins in Surgery Planning is the New Way Forward